kabutan

DAIKEN MEDICAL, 34% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend

Thu May 15, 2025 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE Std] announced its financial results after the market closed on May 15th (16:00). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 increased 4.1% from the previous period to 1.51 billion yen. However, for the fiscal year ending March 2026, the ordinary profit is expected to drop by 33.8% from the previous period to 1 billion yen.

At the same time, the company increased the annual dividend for the previous term from 22 yen to 23 yen (compared to 21 yen in the prior term), and has decided to reduce the dividend this fiscal year to 20 yen, a decrease of 3 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the ordinary profit decreased to 0.19 billion yen, a 6.3% decrease compared to the same period last year. The operating profit margin remained almost flat, changing from 8.7% in the same period last year to 8.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 9,137 1,054 1,053 712 24.8 20 May 15, 2023 J-GAAP
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 9,951 1,512 1,510 1,097 38.2 23 May 15, 2025 J-GAAP
YoY +2.1% +4.9% +4.1% +11.0% +11.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 10,100 1,500 1,500 1,030 35.9 22 May 15, 2024 J-GAAP
Mar, 2025 Results 9,951 1,512 1,510 1,097 38.2 23 May 15, 2025 J-GAAP
Revision Rate -1.5% +0.8% +0.7% +6.5% +6.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 4,914 836 836 608 21.2 9 Oct 31, 2024 J-GAAP
Apr - Sep, 2025 Guidance 5,120 460 455 320 11.1 9 May 15, 2025 J-GAAP
YoY +4.2% -45.0% -45.6% -47.4% -47.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 9,951 1,512 1,510 1,097 38.2 23 May 15, 2025 J-GAAP
Mar, 2026 Guidance 10,500 1,010 1,000 700 24.4 20 May 15, 2025 J-GAAP
YoY +5.5% -33.2% -33.8% -36.2% -36.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 2,344 205 208 100 3.5 8.7 May 15, 2024 J-GAAP
Apr - Jun, 2024 2,395 397 398 289 10.1 16.6 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 2,751 479 479 349 12.2 17.4 Jan 31, 2025 J-GAAP
Jan - Mar, 2025 2,286 197 195 140 4.9 8.6 May 15, 2025 J-GAAP
YoY -2.5% -3.9% -6.3% +40.0% +40.2%

Related Articles